• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 20 Mar

    Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

    - Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the subtype of congenital ichthyosis - BASKING RIDGE, NJ, March 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical… Read More..

    Share this:
  • 20 Mar

    Verde Bio Holdings Provides Third Quarter Corporate Update

    FRISCO, TX, March 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Verde Bio Holdings, Inc. (OTCQB: VBHI), a growing oil and gas royalty company, today issued its third quarter shareholder update, along with its 10-Q filing with the highlights of the Quarter and what is in store for the future.… Read More..

    Share this:
  • 16 Mar

    SuperCom Receives $7.1 Million Follow-On Order by Romania’s Ministry of Interior

    TEL AVIV, Israel, March 16, 2023 /PRNewswire/ SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, is pleased to announce that, together with its local partner, it received a second order valued at approximately $7.1 million from Romania's Ministry of Interior for its National Electronic… Read More..

    Share this:
« Previous 1 … 178 179 180 181 182 … 252 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact